Abstract
Vasoactive intestinal polypeptide receptor 1 (VPAC1) and epidermal growth factor receptor (EGFR) are associated with signal transduction pathways relevant to neuroblastoma, cancer of breast, prostate and lungs. In order to identify appropriate ligand analogues for simultaneous inhibition of EGFR and VPAC1, in-silico homology modelling of VPAC1 and its characterization by molecular interaction studies have been undertaken. Homology modelling was performed with the Swiss Model and validation of the predicted 3D structure was carried out using PROCHECK and RAMPAGE. Ramachandran’s plot of the predicted structure from this two software revealed that 92% and 94% of the residues were in the most favoured region, respectively. Compounds screened from Naturally Occurring Plant-based Anti-Cancerous Compound-Activity-Target (NPACT) database having strong interactions with EGFR were further checked for ADMET properties. Molecular interaction studies revealed four compounds namely Fisetin, Genistein, Tectorigenin, and Tephrosin docked with VPAC1 having respective binding energies of −7.1, −6.98, −6.9 and − 6.61 kcal/mol. Fisetin and Genistein with a rotatable bond and lower molecular weight increased their drug-likeness than the others. Therefore, simultaneous inhibition of VPAC1 and EGFR, in turn, might inhibit the progression of breast carcinoma. The results obtained were further substantiated by comparing them with positive and negative controls. Quercetin was used as positive control, and strong binding energy of −7.54 kcal/mol with EGFR is in accordance with experimental evidence. 3-O-cis-p coumaroyl alphitolic acid was used as negative control, where docking was not possible in absence of binding with either EGFR or VIPR1.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Audain E, Ramos Y, Hermjakob H, Flower DR, Perez-Riverol Y (2015) Accurate estimation of isoelectric point of protein and peptide based on amino acid sequences. Bioinformatics 32:821–827. https://doi.org/10.1093/bioinformatics/btv674
Bachmair A, Finley D, Varshavsky A (1986) In vivo half-life of a protein is a function of its amino-terminal residue. Science (80- ) 234:179–186. https://doi.org/10.1126/science.3018930
Benkert P, Künzli M, Schwede T (2009) QMEAN server for protein model quality estimation. Nucleic Acids Res 37:W510–W514. https://doi.org/10.1093/nar/gkp322
Bhasin M, Raghava GPS (2004) ESLpred: SVM-based method for subcellular localization of eukaryotic proteins using dipeptide composition and PSI-BLAST. Nucleic Acids Res 32. https://doi.org/10.1093/nar/gkh350
Bhat FA, Sharmila G, Balakrishnan S, Arunkumar R, Elumalai P, Suganya S, Raja Singh P, Srinivasan N, Arunakaran J (2014) Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway. J Nutr Biochem 25:1132–1139. https://doi.org/10.1016/j.jnutbio.2014.06.008
Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, Kiefer F, Cassarino TG, Bertoni M, Bordoli L, Schwede T (2014) SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 42:W252–W258. https://doi.org/10.1093/nar/gku340
Bordoli L, Kiefer F, Arnold K, Benkert P, Battey J, Schwede T (2009) Protein structure homology modeling using SWISS-MODEL workspace. Nat Protoc 4:1–13. https://doi.org/10.1038/nprot.2008.197
Bukowski R, Wąsowicz K (2015) Expression of VPAC1 receptor at the level of mRNA and protein in the porcine female reproductive system. Pol J Vet Sci 18:199–206. https://doi.org/10.1515/pjvs-2015-0025
Canutescu AA, Dunbrack RL (2003) Cyclic coordinate descent: a robotics algorithm for protein loop closure. Protein Sci 12:963–972. https://doi.org/10.1110/ps.0242703
Cavasotto CN, Phatak SS (2009) Homology modeling in drug discovery: current trends and applications. Drug Discov Today 14:676–683
Ciechanover A, Schwartz AL (1989) How are substrates recognized by the ubiquitin-mediated proteolytic system. Trends Biochem Sci 14:483–488
Couvineau A, Laburthe M (2012) VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins. Br J Pharmacol 166:42–50
Eastman P, Swails J, Chodera JD, McGibbon RT, Zhao Y, Beauchamp KA, Wang LP, Simmonett AC, Harrigan MP, Stern CD, Wiewiora RP, Brooks BR, Pande VS (2017) OpenMM 7: rapid development of high performance algorithms for molecular dynamics. PLoS Comput Biol 13:e1005659. https://doi.org/10.1371/journal.pcbi.1005659
Ghosh A, Parai B (2008) Protein secondary structure prediction using distance based classifiers. Int J Approx Reason 47:37–44. https://doi.org/10.1016/j.ijar.2007.03.007
Gómez-Verjan JC, Rodríguez-Hernández KD, Reyes-Chilpa R (2017) Bioactive Coumarins and Xanthones from Calophyllum genus and analysis of their Druglikeness and toxicological properties. In: Studies in Natural Products Chemistry. pp 277–307
Gonda DK, Bachmair a, Wünning I et al (1989) Universality and structure of the N-end rule. J Biol Chem 264:16700–16712
Grasso EJ, Sottile AE, Coronel CE (2016) Structural prediction and in silico physicochemical characterization for mouse caltrin I and bovine caltrin proteins. Bioinform Biol Insights 10:225–236. https://doi.org/10.4137/BBI.S38191
Guruprasad K, Reddy BVB, Pandit MW (1990) Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Eng Des Sel 4:155–161. https://doi.org/10.1093/protein/4.2.155
Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, Vaudry D, Vaudry H, Waschek JA, Said SI (2012) Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol 166:4–17
Ikai A (1980) Thermostability and aliphatic index of globular proteins. J Biochem 1898:1895–1898. https://doi.org/10.1017/CBO9781107415324.004
Ilangovan SS, Sen S (2016) Simultaneous inhibition of EGFR and MET receptors with phytochemical conjugated magnetic nanocarriers: in silico and in vitro study. RSC Adv 6:80121–80132. https://doi.org/10.1039/C6RA11821F
Jung JH, Lee JO, Kim JH, Lee SK, You GY, Park SH, Park JM, Kim EK, Suh PG, An JK, Kim HS (2010) Quercetin suppresses HeLa cell viability via AMPK-induced HSP70 and EGFR down-regulation. J Cell Physiol:n/a. https://doi.org/10.1002/jcp.22049
Kashyap A, Chetia D, Rudrapal M (2016) Synthesis, antimalarial activity evaluation and drug-likeness study of some new quinoline-lawsone hybrids. Indian J Pharm Sci 78:801–809. https://doi.org/10.4172/pharmaceutical-sciences.1000186
Kitchen DB, Decornez H, Furr JR, Bajorath J (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 3:935–949. https://doi.org/10.1038/nrd1549
Krivov GG, Shapovalov MV, Dunbrack RL (2009) Improved prediction of protein side-chain conformations with SCWRL4. Proteins 77:778–795. https://doi.org/10.1002/prot.22488
Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283–291. https://doi.org/10.1107/S0021889892009944
Lee SM, Min BS, Lee CG, Kim KS, Kho YH (2003) Cytotoxic triterpenoids from the fruits of Zizyphus jujuba. Planta Med 69:1051–1054. https://doi.org/10.1055/s-2003-45155
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and develop ment settings. Adv Drug Deliv Rev 23:3–25. https://doi.org/10.1016/S0169-409X(00)00129-0
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2012) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 64:4–17
Lobley A, Sadowski MI, Jones DT (2009) pGenTHREADER and pDomTHREADER: new methods for improved protein fold recognition and superfamily discrimination. Bioinformatics 25:1761–1767. https://doi.org/10.1093/bioinformatics/btp302
Lovell SC, Davis IW, Arendall WB et al (2003) Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins 50:437–450. https://doi.org/10.1002/prot.10286
Mangal M, Sagar P, Singh H, Raghava GPS, Agarwal SM (2013) NPACT: Naturally occurring plant-based anti-cancer compound-activity-target database. Nucleic Acids Res 41. https://doi.org/10.1093/nar/gks1047
Mao M-G, Jiang J-L, Jiang Z-Q, Liu RT, Zhang QY, Gui JF (2018) Molecular characterization of caspase members and expression response to nervous necrosis virus outbreak in Pacific cod. Fish Shellfish Immunol 74:559–566. https://doi.org/10.1016/j.fsi.2018.01.004
Matsukawa Y, Nishino H, Yoshida M, Sugihara H, Katsura K, Takamatsu T, Okuzumi J, Matsumoto K, Sato-Nishimori F, Sakai T (2002) Quercetin enhances tumorigenicity induced by N-ethyl-N′-nitro-N-nitrosoguanidine in the duodenum of mice. Environ Health Prev Med 6:235–239. https://doi.org/10.1007/BF02897975
Moody TW, Jensen RT (2006) Breast cancer VPAC1 receptors. In: Annals of the New York Academy of Sciences. pp 436–439
Moody TW, Nuche-Berenguer B, Nakamura T, Jensen RT (2016) EGFR transactivation by peptide G protein-coupled receptors in Cancer. Curr Drug Targets 17:520–528
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639–1662. https://doi.org/10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
Owens DR (2002) New horizons--alternative routes for insulin therapy. Nat Rev Drug Discov 1:529–540. https://doi.org/10.1038/nrd836
Palm K, Luthman K, Ungell AL et al (1996) Correlation of drug absorption with molecular surface properties. J Pharm Sci 85:32–39. https://doi.org/10.1021/js950285r
Ramakrishnan C, Ramachandran GN (1965) Stereochemical criteria for polypeptide and protein chain ConformationsII. Allowed conformations for a pair of peptide units. Biophys J 5:909–933. https://doi.org/10.1016/S0006-3495(65)86759-5
Rumelhart DE, Hinton GE, Williams RJ (1986) Learning representations by back-propagating errors. Nature 323:533–536. https://doi.org/10.1038/323533a0
Rumpi G, Ad U, Ak R, Samik A (2017) Structural Analysis of Cytochrome C Genes of Major Carp and Utility of Forensic Investigation 1:1–8
Sastry KS, Chouchane AI, Wang E, Kulik G, Marincola FM, Chouchane L (2017) Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling. Cell Death Dis 8:e2844. https://doi.org/10.1038/cddis.2017.226
Scott MS, Calafell SJ, Thomas DY, Hallett MT (2005) Refining protein subcellular localization. PLoS Comput Biol 1:e66. https://doi.org/10.1371/journal.pcbi.0010066
Seo HS, DeNardo DG, Jacquot Y et al (2006) Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Res Treat 99:121–134. https://doi.org/10.1007/s10549-006-9191-2
Shapovalov MV, Dunbrack RL (2011) A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions. Structure 19:844–858. https://doi.org/10.1016/j.str.2011.03.019
Shin M, Lee BM, Kim O, Tran HNK, Lee S, Hwangbo C, Min BS, Lee JH (2018) Triterpenoids from Ziziphus jujuba induce apoptotic cell death in human cancer cells through mitochondrial reactive oxygen species production. Food Funct 9:3895–3905. https://doi.org/10.1039/c8fo00526e
Srinivasan M (2014) IN-SILICO DRUG DESIGNING FROM FLAVONOIDS DERIVATIVES OF
Tang M, Zhou Y, Li Y, Zou J, Yang B, Cai L, Zhang X, Liu Q (2017) Hydrogen donors and acceptors and basic amino acids jointly contribute to carcinogenesis. Med Hypotheses 98:42–44. https://doi.org/10.1016/j.mehy.2016.11.014
Tobias JW, Shrader TE, Rocap G, Varshavsky A (1991) The N-end rule in bacteria. Science 254:1374–1377. https://doi.org/10.1126/science.1962196
Valdehita A, Bajo AM, Schally AV, Varga JL, Carmena MJ, Prieto JC (2009) Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2 in human breast cancer cells. Mol Cell Endocrinol 302:41–48. https://doi.org/10.1016/j.mce.2008.11.024
Valdehita A, Carmena MJ, Collado B, Prieto JC, Bajo AM (2007) Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells. Regul Pept 144:101–108. https://doi.org/10.1016/j.regpep.2007.06.006
Van Der Spoel D, Lindahl E, Hess B et al (2005) GROMACS: fast, flexible, and free. J Comput Chem 26:1701–1718
Varshavsky A (1997) The N-end rule pathway of protein degradation. Genes Cells 2:13–28. https://doi.org/10.1016/0309-1651(90)90142-L
Walters WP, Murcko MA (2002) Prediction of “drug-likeness.” Adv Drug Deliv Rev 54:255–271, Prediction of ‘drug-likeness’
Williams KL, Hochstrasser DF (1997) Introduction to the proteome. Proteome Res New Front Funct genomics 1–12. https://doi.org/10.1007/978-3-662-03493-4_1
Yu C-S, Chen Y-C, Lu C-H, Hwang J-K (2006) Prediction of protein subcellular localization. Proteins 64:643–651. https://doi.org/10.1002/prot.21018
Yu C-S, Lin C-J, Hwang J-K (2004) Predicting subcellular localization of proteins for gram-negative bacteria by support vector machines based on n-peptide compositions. Protein Sci 13:1402–1406. https://doi.org/10.1110/ps.03479604
Ziaei S, Halaby R (2017) Dietary Isoflavones and breast Cancer risk. Medicines 4:18. https://doi.org/10.3390/medicines4020018
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PNG 477 kb)
Rights and permissions
About this article
Cite this article
Sarkar, A., Sen, S. 3D structure prediction of VAPC1 and identification of dual natural inhibitors for VPAC1 and EGFR. J Bioenerg Biomembr 51, 89–102 (2019). https://doi.org/10.1007/s10863-019-09790-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-019-09790-y